Does the media favor CERT or EVH?

In the previous week, Certara had 2 more articles in the media than Evolent Health. MarketBeat recorded 4 mentions for Certara and 2 mentions for Evolent Health. Certara's average media sentiment score of 0.98 beat Evolent Health's score of 0.45 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Evolent Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, GDRX or EVH?

GoodRx has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.42 $30.44M $0.04 82.75 Evolent Health $1.88B 0.22 -$534.51M -$4.57 N/A

Is GDRX or EVH more profitable?

GoodRx has a net margin of 2.07% compared to Evolent Health's net margin of -24.08%. GoodRx's return on equity of 7.22% beat Evolent Health's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Evolent Health -24.08% -4.27% -1.06%

Does the media favor GDRX or EVH?

In the previous week, GoodRx and GoodRx both had 2 articles in the media. GoodRx's average media sentiment score of 1.79 beat Evolent Health's score of 0.45 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Evolent Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to EVH or TDOC?

In the previous week, Teladoc Health had 9 more articles in the media than Evolent Health. MarketBeat recorded 11 mentions for Teladoc Health and 2 mentions for Evolent Health. Teladoc Health's average media sentiment score of 0.56 beat Evolent Health's score of 0.45 indicating that Teladoc Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Teladoc Health 5 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Evolent Health (EVH) Competitors

$3.64 +0.04 (+0.97%)

Closing price 09/28/2026 03:58 PM Eastern

Extended Trading

$3.66 +0.01 (+0.27%)

As of 09/28/2026 07:30 PM Eastern

Compare

EVH vs. CERT, GDRX, TDOC, HSTM, and SOPH

Should you buy Evolent Health stock or one of its competitors? Evolent Health's main competitors and comparable companies include Certara (CERT), GoodRx (GDRX), Teladoc Health (TDOC), HealthStream (HSTM), and SOPHiA GENETICS (SOPH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Evolent Health compare to Certara?

Certara (NASDAQ:CERT) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

Certara has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

Certara currently has a consensus target price of $8.28, indicating a potential downside of 9.33%. Evolent Health has a consensus target price of $5.96, indicating a potential upside of 63.63%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63

In the previous week, Certara had 2 more articles in the media than Evolent Health. MarketBeat recorded 4 mentions for Certara and 2 mentions for Evolent Health. Certara's average media sentiment score of 0.98 beat Evolent Health's score of 0.45 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara has higher earnings, but lower revenue than Evolent Health. Certara is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.33	-$1.60M	-$0.45	N/A
Evolent Health	$1.88B	0.22	-$534.51M	-$4.57	N/A

74.0% of Certara shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 1.5% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Certara has a net margin of -16.75% compared to Evolent Health's net margin of -24.08%. Certara's return on equity of 3.86% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Evolent Health	-24.08%	-4.27%	-1.06%

Summary

Certara beats Evolent Health on 11 of the 17 factors compared between the two stocks.

How does Evolent Health compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, GoodRx and GoodRx both had 2 articles in the media. GoodRx's average media sentiment score of 1.79 beat Evolent Health's score of 0.45 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

GoodRx presently has a consensus price target of $4.23, indicating a potential upside of 27.71%. Evolent Health has a consensus price target of $5.96, indicating a potential upside of 63.63%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63

63.8% of GoodRx shares are held by institutional investors. 5.9% of GoodRx shares are held by insiders. Comparatively, 1.5% of Evolent Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

GoodRx has a beta of 1.59, indicating that its share price is 59% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

GoodRx has a net margin of 2.07% compared to Evolent Health's net margin of -24.08%. GoodRx's return on equity of 7.22% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Evolent Health	-24.08%	-4.27%	-1.06%

GoodRx has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.42	$30.44M	$0.04	82.75
Evolent Health	$1.88B	0.22	-$534.51M	-$4.57	N/A

Summary

GoodRx beats Evolent Health on 11 of the 15 factors compared between the two stocks.

How does Evolent Health compare to Teladoc Health?

Evolent Health (NYSE:EVH) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

Teladoc Health has a net margin of -7.13% compared to Evolent Health's net margin of -24.08%. Evolent Health's return on equity of -4.27% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-24.08%	-4.27%	-1.06%
Teladoc Health	-7.13%	-12.15%	-5.83%

76.8% of Teladoc Health shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Evolent Health presently has a consensus target price of $5.96, indicating a potential upside of 63.63%. Teladoc Health has a consensus target price of $7.54, indicating a potential upside of 27.83%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Teladoc Health had 9 more articles in the media than Evolent Health. MarketBeat recorded 11 mentions for Teladoc Health and 2 mentions for Evolent Health. Teladoc Health's average media sentiment score of 0.56 beat Evolent Health's score of 0.45 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teladoc Health	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Teladoc Health has higher revenue and earnings than Evolent Health. Teladoc Health is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.22	-$534.51M	-$4.57	N/A
Teladoc Health	$2.53B	0.42	-$200.32M	-$0.99	N/A

Evolent Health has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, meaning that its share price is 112% more volatile than the broader market.

Summary

Teladoc Health beats Evolent Health on 9 of the 16 factors compared between the two stocks.

How does Evolent Health compare to HealthStream?

HealthStream (NASDAQ:HSTM) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

HealthStream has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market. Comparatively, Evolent Health has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

HealthStream presently has a consensus price target of $27.00, indicating a potential downside of 7.34%. Evolent Health has a consensus price target of $5.96, indicating a potential upside of 63.63%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63

HealthStream has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$304.06M	2.80	$18.34M	$0.72	40.47
Evolent Health	$1.88B	0.22	-$534.51M	-$4.57	N/A

In the previous week, Evolent Health had 1 more articles in the media than HealthStream. MarketBeat recorded 2 mentions for Evolent Health and 1 mentions for HealthStream. HealthStream's average media sentiment score of 1.79 beat Evolent Health's score of 0.45 indicating that HealthStream is being referred to more favorably in the media.

Company	Overall Sentiment
HealthStream	Very Positive
Evolent Health	Neutral

69.6% of HealthStream shares are held by institutional investors. 20.4% of HealthStream shares are held by company insiders. Comparatively, 1.5% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

HealthStream has a net margin of 6.60% compared to Evolent Health's net margin of -24.08%. HealthStream's return on equity of 6.81% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.60%	6.81%	4.64%
Evolent Health	-24.08%	-4.27%	-1.06%

Summary

HealthStream beats Evolent Health on 10 of the 16 factors compared between the two stocks.

How does Evolent Health compare to SOPHiA GENETICS?

SOPHiA GENETICS (NASDAQ:SOPH) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Evolent Health has a net margin of -24.08% compared to SOPHiA GENETICS's net margin of -93.86%. Evolent Health's return on equity of -4.27% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%
Evolent Health	-24.08%	-4.27%	-1.06%

SOPHiA GENETICS has higher earnings, but lower revenue than Evolent Health. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$77.27M	9.22	-$79M	-$1.15	N/A
Evolent Health	$1.88B	0.22	-$534.51M	-$4.57	N/A

SOPHiA GENETICS has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market. Comparatively, Evolent Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

In the previous week, SOPHiA GENETICS had 1 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for SOPHiA GENETICS and 2 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.45 beat SOPHiA GENETICS's score of -0.06 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Overall Sentiment
SOPHiA GENETICS	Neutral
Evolent Health	Neutral

SOPHiA GENETICS presently has a consensus price target of $10.00, indicating a potential upside of 17.79%. Evolent Health has a consensus price target of $5.96, indicating a potential upside of 63.63%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than SOPHiA GENETICS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63

31.6% of SOPHiA GENETICS shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by insiders. Comparatively, 1.5% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Evolent Health beats SOPHiA GENETICS on 9 of the 16 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EVH vs. The Competition

Export

Metric	Evolent Health	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$408.14M	$1.77B	$7.33B	$23.02B
Dividend Yield	N/A	3.98%	2.52%	3.68%
P/E Ratio	-0.80	20.89	274.75	27.75
Price / Sales	0.22	88.32	617.30	20.63
Price / Cash	0.77	31.74	28.02	19.27
Price / Book	1.03	6.19	10.53	4.65
Net Income	-$534.51M	-$18.66M	$3.50B	$1.07B
7 Day Performance	-3.88%	-0.01%	-2.64%	-2.56%
1 Month Performance	-20.93%	0.27%	-3.76%	-5.60%
1 Year Performance	-58.34%	-19.07%	13.56%	6.05%

Evolent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EVH Evolent Health	3.1818 of 5 stars	$3.65 +1.0%	$5.96 +63.6%	-59.3%	$408.14M	$1.88B	N/A	4,200
CERT Certara	1.5667 of 5 stars	$8.42 -1.9%	$8.28 -1.7%	-22.6%	$1.31B	$418.84M	N/A	1,576	High Trading Volume
GDRX GoodRx	4.1553 of 5 stars	$3.38 -0.6%	$4.23 +25.1%	-18.1%	$1.16B	$796.85M	84.52	697	Positive News
TDOC Teladoc Health	3.2355 of 5 stars	$6.32 +0.6%	$7.54 +19.3%	-27.6%	$1.14B	$2.53B	N/A	5,600
HSTM HealthStream	2.5584 of 5 stars	$29.23 +0.1%	$27.00 -7.6%	+0.0%	$852.79M	$304.06M	40.60	1,160	Positive News High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EVH) was last updated on 9/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolent Health (EVH) Competitors

EVH vs. CERT, GDRX, TDOC, HSTM, and SOPH

How does Evolent Health compare to Certara?

Summary

How does Evolent Health compare to GoodRx?

Summary

How does Evolent Health compare to Teladoc Health?

Summary

How does Evolent Health compare to HealthStream?

Summary

How does Evolent Health compare to SOPHiA GENETICS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolent Health (EVH) Competitors

EVH vs. CERT, GDRX, TDOC, HSTM, and SOPH

How does Evolent Health compare to Certara?

Which has more volatility and risk, CERT or EVH?

Do analysts rate CERT or EVH?

Does the media favor CERT or EVH?

Which has preferable earnings and valuation, CERT or EVH?

Do institutionals & insiders hold more shares of CERT or EVH?

Is CERT or EVH more profitable?

Summary

How does Evolent Health compare to GoodRx?

Does the media favor GDRX or EVH?

Do analysts recommend GDRX or EVH?

Do insiders & institutionals hold more shares of GDRX or EVH?

Which has more risk & volatility, GDRX or EVH?

Is GDRX or EVH more profitable?

Which has better valuation and earnings, GDRX or EVH?

Summary

How does Evolent Health compare to Teladoc Health?

Is EVH or TDOC more profitable?

Do institutionals and insiders believe in EVH or TDOC?

Do analysts prefer EVH or TDOC?

Does the media refer more to EVH or TDOC?

Which has higher earnings and valuation, EVH or TDOC?

Which has more volatility and risk, EVH or TDOC?

Summary

How does Evolent Health compare to HealthStream?

Which has more volatility and risk, HSTM or EVH?

Do analysts recommend HSTM or EVH?

Which has preferable valuation & earnings, HSTM or EVH?

Does the media refer more to HSTM or EVH?

Do institutionals & insiders believe in HSTM or EVH?

Is HSTM or EVH more profitable?

Summary

How does Evolent Health compare to SOPHiA GENETICS?

Is SOPH or EVH more profitable?

Which has stronger earnings and valuation, SOPH or EVH?

Which has more volatility and risk, SOPH or EVH?

Does the media refer more to SOPH or EVH?

Do analysts rate SOPH or EVH?

Do insiders and institutionals have more ownership in SOPH or EVH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools